About EPIDIOLEX
EPIDIOLEX is a Healthcare company based in Salisbury (United Kingdom) founded in 2013. It offers cannabidiol medication for seizure treatment in LGS, Dravet, and TSC patients. It operates on a B2B model. EPIDIOLEX offers products and services including EPIDIOLEX. Its focus areas include Biotechnology, Pharmaceuticals, Antiepileptic Drugs and Prescription Medicines.
Company details
Jazz Pharmaceuticals develops EPIDIOLEX, an FDA-approved prescription cannabidiol to treat seizures linked to Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients aged one year and older. It is prescribed by doctors and monitored for potential liver issues, with support like nurse navigators for US-based users. The company provides resources and educational programs to assist patients and caregivers in managing epilepsy-related challenges.
- Headquarters Salisbury, United Kingdom
- SectorsHealthcare
- Phone•••• ••••
- Website epidiolex.com
- Social Facebook YouTube
Products & Services of EPIDIOLEX
EPIDIOLEX offers a comprehensive portfolio of products and services, including EPIDIOLEX.
Treats seizures in LGS, Dravet syndrome, and TSC patients.
Apps and channels of EPIDIOLEX
its YouTube channel EPIDIOLEX (cannabidiol) has 1.15K subscribers and 30 videos.
Videos from EPIDIOLEX
The most watched videos on EPIDIOLEX's YouTube channel, EPIDIOLEX (cannabidiol) (1.15K subscribers). Click a video to play it here.
More on EPIDIOLEX (cannabidiol).
Web traffic of EPIDIOLEX
Websites that share an audience with EPIDIOLEX (epidiolex.com).
Websites whose visitors overlap most with EPIDIOLEX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ceribell.com | 73% | 31.2K | #1,005,164 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as EPIDIOLEX (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epidiolex
Complete news archive for EPIDIOLEX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EPIDIOLEX
EPIDIOLEX was founded in 2013.
EPIDIOLEX is headquartered in Salisbury, United Kingdom. It is registered at Salisbury, Wiltshire, United Kingdom.
Jazz Pharmaceuticals develops EPIDIOLEX, an FDA-approved prescription cannabidiol to treat seizures linked to Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients aged one year and older. It is prescribed by doctors and monitored for potential liver issues, with support like nurse navigators for US-based users. The company provides resources and educational programs to assist patients and caregivers in managing epilepsy-related challenges.
EPIDIOLEX offers EPIDIOLEX.